Evidence map›Paper›PMID 36173177›Full record

ArticleProtein science : a publication of the Protein Society2022

Structure determination of an unstable macromolecular complex enabled by nanobody-peptide bridging.

Josefine Lorentzen, Dennis Vestergaard Pedersen, Trine Amalie Fogh Gadeberg, Gregers Rom Andersen

Open access · hybridAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Acquired drivers of C3 glomerulopathy.Clinical kidney journal · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Josefine LorentzenDepartment of Molecular Biology and Genetics, Section for Protein Science, Aarhus Universitet, Aarhus, Denmark.
Dennis Vestergaard PedersenDepartment of Molecular Biology and Genetics, Section for Protein Science, Aarhus Universitet, Aarhus, Denmark.
Trine Amalie Fogh GadebergDepartment of Molecular Biology and Genetics, Section for Protein Science, Aarhus Universitet, Aarhus, Denmark.
Gregers Rom AndersenDepartment of Molecular Biology and Genetics, Section for Protein Science, Aarhus Universitet, Aarhus, Denmark.ORCID 0000-0001-6292-3319
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structure determination of macromolecular complexes is challenging if subunits can dissociate during crystallization or preparation of electron microscopy grids. We present an approach where a labile complex is stabilized by linking subunits though introduction of a peptide tag in one subunit that is recognized by a nanobody tethered to a second subunit. This allowed crystal structure determination at 3.9 Å resolution of the highly non-globular 320 kDa proconvertase formed by complement components C3b, factor B, and properdin. Whereas the binding mode of properdin to C3b is preserved, an internal rearrangement occurs in the zymogen factor B von Willebrand domain type A domain compared to the proconvertase not bound to properdin. The structure emphasizes the role of two noncanonical loops in thrombospondin repeats 5 and 6 of properdin in augmenting the activity of the C3 convertase. We suggest that linking of subunits through peptide specific tethered nanobodies represents a simple alternative to approaches like affinity maturation and chemical cross-linking for the stabilization of large macromolecular complexes. Besides applications for structural biology, nanobody bridging may become a new tool for biochemical analysis of unstable macromolecular complexes and in vitro selection of highly specific binders for such complexes.

Indexed as

ProperdinSingle-Domain AntibodiesComplement C3-C5 ConvertasesComplement Factor BEnzyme PrecursorsMacromolecular SubstancesThrombospondinsComplement C3-C5 ConvertasesComplement Factor BEnzyme PrecursorsMacromolecular SubstancesProperdinSingle-Domain AntibodiesThrombospondinscomplementconvertaseinnate immunitymacromolecular complexesnanobodystructural biology

Identifiers

PMID36173177
PMCPMC9601772
OpenAlexW4297383382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.